logo IDIBELL
Català  |   Castellano  |   English
Search
The InstituteResearchWhat's onCalendarPlatformsJob offers
 

What's on
imatge 55916/05/2013

Identified a family with neurofibromatosis type 1 and early breast cancer in which there are mutations in NF1 and BRCA1

Researchers of the IDIBELL and the Hospital Vall d'Hebron have studied a family affected by both type 1 neurofibromatosis and early breast cancer and they have detected mutations in NF1 and BRCA1 genes responsible for the two diseases, respectively.

More information

News
23/05/2013
Developed a model of radiotherapy in mice to test new chemotherapy treatments for brain metastases
foto 563
21/05/2013
Vicente Felipo: “We want to identify the mechanisms that lead to minimal Hepatic Encephalopathy to reverse the cognitive and motor impairment”
foto 561
21/05/2013
Josep Marco: ''we have an approximate system to measure amounts''
foto 562
17/05/2013
Gabriel Capellá, appointed new head of research and innovation of the Health Department of the Generalitat de Catalunya
foto 560

More news

Reports
19/03/2012
Research for the fun of it?
foto 255
12/03/2012
Brain of plasticine
foto 254
29/02/2012
''Research may not result in a prompt treatment but to know that somebody is investigating makes the parents feel more accompanied''
foto 253
11/10/2011
Statistic adds value to scientific results
foto 252

More news

Interview
foto 5523/04/2013
Artur Llobet: “Investing in frogs is not unreasonable”

April 24 marks the World Day of laboratory animals. Everybody thinks about mice but IDIBELL also works with other animal models such as worms, pigs or frogs and others.

The researcher Artur Llobet of the cellular and molecular neurobiology group is working with a species of frog, Xenopus tropicalis, able to regenerate brain functions.

foto 5410/04/2013
Esteve Fernández: ''Smoking in the car is worse than smoking in the worst dump where now is banned''

Seven years after the entry into force of the first smoking law, we are beginning to see the benefits in public health. Benefits, according Esteve Fernandez, head of the tobacco control unit of ICO will increase when we analyze the impact of the second law that took effect in 2011, much more restrictive.

More interviews

 
© 2013 Institut d'Investigació Biomèdica de Bellvitge


Results by pageInitial date
Select date
TitleFinal date
Select date
Search


Your password is about to expire. Please, write in a new password to continue

Remember this password allows you to access to all IDIBELL’s web applications
New password:
Confirm new password:

Accept



Your password is about to expire. Please, write in a new password to continue

Remember this password allows you to access to all IDIBELL’s web applications
New password:
Confirm new password:

Accept


Cancell

Passwords doesn’t match
The password must have at least 6 characters
The new password can not contain special characters
User register

Name
Surname
Second Surname
E-mail
User
Password
Language


Accept


Cancell




You have not yet answered the internal personal satisfaction survey. It will not take you more than five minutes. Your opinion is very important to improve IDIBELL.

Do you want to complete the survey now?

Yes

No




Further personal and contact information is needed to maintain IDIBELL databases.

Do you wish to fill the form now?

Yes

No